Clinical Trials in Cleveland

Showing 5381-5400 of 19,775 trials

SURPASS Impella 5.5 Study

NCT05100836

A multi-center, prospective \& retrospective, observational single-arm study of the clinical outcomes up to one year collected from electronic health records of patients which have undergone standard of care implantation of Impella 5.5, regardless of clinical situation or indication. All patients will be enrolled via an IRB-approved Waiver of Informed Consent and HIPAA Authorization. All patients who were supported retrospectively (prior to site IRB approval) with Impella 5.5 at the investigative site will be entered into the SURPASS registry and specified as the retrospective cohort.

Cardiogenic ShockAcute Decompensated Heart Failure

Abiomed Inc.1,017 participantsStarted Sep 2020

Los Angeles, California, United States • Orlando, Florida, United States • Tampa, Florida, United States +12 more locations

COMPLETED< 1 mile

A Retrospective Chart Review Study of Patients With Chronic Lung Allograft Dysfunction-Bronchiolitis Obliterans Syndrome (CLAD-BOS) Post Lung Transplantation

NCT06503770

The aim of this study is to describe the forced expiratory volume in 1 second (FEV1) decline and natural disease evolution in patients affected by CLAD-BOS after lung transplantation and receiving an immunosuppressive therapy as standard of care.

Bronchiolitis Obliterans Syndrome Due to and After Lung Transplantation (Disorder)

Zambon SpA284 participantsStarted Jun 2024

Cleveland, Ohio, United States • Columbus, Ohio, United States • Dallas, Texas, United States +3 more locations

SURPASS Impella 5.5 Study

A Retrospective Chart Review Study of Patients With Chronic Lung Allograft Dysfunction-Bronchiolitis Obliterans Syndrome (CLAD-BOS) Post Lung Transplantation

Find Trials by Condition in Cleveland

An Efficacy and Safety Study of AG-221 (CC-90007) Versus Conventional Care Regimens in Older Subjects With Late Stage Acute Myeloid Leukemia Harboring an Isocitrate Dehydrogenase 2 Mutation

Stopping Aminosalicylate Therapy in Inactive Crohn's Disease

Early Feasibility Study of the Neovasc Tiara™ Mitral Valve System

PRimary Care Opioid Use Disorders Treatment (PROUD) Trial

A Study of the Drugs AGN-242428 and AGN-231868 in Participants With Dry Eye Disease

Apixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation Therapy

Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)

A Second Intermediate-Size Expanded Access Protocol (EAP) for Pridopidine in People With Amyotrophic Lateral Sclerosis (Pridopidine EAP 2)

MEOI and HRQoL in CLL Patients Treated With BTKis

FIT-ATOMIC Exercise Feasibility Trial

Safety and Efficacy Study of CFI-402411 in Subjects With Advanced Solid Malignancies

StimRouter Registry Clinical Protocol

Efficacy, Safety and Pharmacokinetics of Rilzabrutinib in Patients With Warm Autoimmune Hemolytic Anemia (wAIHA)

Clinical Trial of Approaches to Prostate Cancer Surgery

Efficacy & Safety of rAd-IFN Administered With Celecoxib & Gemcitabine in Patients With Malignant Pleural Mesothelioma

BCMA-directed CAR-T Cell Therapy in Adult Patients With Multiple Myeloma

Safety, Tolerability and Acceptability of Long-Acting Cabotegravir (CAB LA) for the Prevention of HIV Among Adolescent Males

DiEtary Sodium Intake Effects on Ertugliflozin-induced Changes in GFR, reNal Oxygenation and Systemic Hemodynamics: the DESIGN Study, a Randomized, Placebo-controlled, Cross-over Study With Ertugliflozin in People With Type 2 Diabetes